Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(11%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_2

11%

Ph not_applicable

11%

Ph phase_1

11%

Ph phase_4

22%

Ph phase_3

44%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

1(11.1%)

Phase 2Efficacy & side effects

1(11.1%)

Phase 3Large-scale testing

4(44.4%)

Phase 4Post-market surveillance

2(22.2%)

N/ANon-phased studies

1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Other(4)

Detailed Status

Completed4

unknown4

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (11.1%)

Phase 21 (11.1%)

Phase 34 (44.4%)

Phase 42 (22.2%)

N/A1 (11.1%)

Trials by Status

completed444%

recruiting111%

unknown444%

Recent Activity

1 active trials

Showing 5 of 9

recruitingnot_applicable

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

NCT06256575

unknownphase_3

the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.

NCT05942547

unknownphase_3

Clinical Trials (9)

Showing 9 of 9 trials

NCT06256575Not Applicable

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

Recruiting

NCT05942547Phase 3

the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.

Unknown

NCT05626166Phase 3

the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis

Unknown

NCT05670457Phase 3

Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer

Unknown

NCT03413618Phase 4

Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis

Completed

NCT03471910Phase 4

Clinical Non-inferiority Study Between Diosmin 600mg & Diosmin + Hesperidin in Symptomatic Chronic Venous Insufficiency

Completed

NCT02134249Phase 2

Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome

Completed

NCT02616731Phase 1

Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD

Unknown

NCT01532882Phase 3

Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs

Completed

All 9 trials loaded

Drug Details

Intervention Type: COMBINATION PRODUCT
Total Trials: 9